MedTrace Logo

Heart Rate Changes Following the Administration of Sugammadex

NCT03294018 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 276

Last updated 2019-10-09

No results posted yet for this study

Summary

This a prospective study when the clinician decides to use sugammadex, heart rate will be recorded every minute for 15 minutes following its administration. If bradycardia occurs and a clinical decision is made to treat it, the medications and doses used will be recorded.

Conditions

  • Bradycardia

Interventions

OTHER

Recording heart rate changes

Recording heart rate changes during planned sugammadex administration.

Sponsors & Collaborators

  • Joseph D. Tobias

    lead OTHER

Eligibility

Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-09-06
Primary Completion
2019-01-10
Completion
2019-01-10

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03294018 on ClinicalTrials.gov